Clinical Trial - Trial HKUCTR-2814
Access comprehensive clinical trial information for HKUCTR-2814 through Pure Global AI's free database. This Phase 2 trial is sponsored by BioAtla, LLC and is currently Not yet recruiting. The study focuses on Neoplasm.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to HKU CLINICAL TRIALS REGISTRY data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
HKUCTR-2814
Phase 2
Not yet recruiting
drug
Trial Details
HKU CLINICAL TRIALS REGISTRY • HKUCTR-2814
Untitled Trial
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 in Patients with Advanced Solid Tumors
Study Focus
Sponsor & Location
BioAtla, LLC
China
Timeline & Enrollment
Phase 2
N/A
Oct 14, 2020
ICD-10 Classifications
Neoplasms
Benign neoplasms
In situ neoplasms
Personal history of other neoplasms
Benign neoplasm: Other specified sites
Data Source
HKU CLINICAL TRIALS REGISTRY
HKUCTR-2814
Non-Device Trial